Jason Valent

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Patient Reported Outcomes

Ejection Fraction

Tyrosine Kinase

Peritoneal Dialysis

Top Venues

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Maroun Bou Zerdan, Jason Valent, Maria Julia Diacovo, Karl Theil, Chakra P. Chaulagain
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia). Advances in hematology 2022 (2022)
Asad Ikram, Joseph P Donnelly, Brett W Sperry, Christy Samaras, Jason Valent, Mazen Hanna
Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (3) (2018)